Cervical screening expansion Opportunity to scale MobileODT’s cervical cancer screening system in low-resource markets, leveraging the DRC pilot and global health priorities to pursue partnerships with national programs, NGOs, and public health agencies seeking affordable, point-of-care diagnostics.

AI enabled efficiency Capitalize on VisualCheck AI and ongoing AI developments to offer enhanced diagnostic accuracy and workflow automation to health systems, enabling remote expert consultations and streamlined case management for large-scale cervical cancer screening initiatives.

Integrated cloud workflows Position the cloud-based platform as a hub for data capture, telemedicine, and EHR interoperability to attract hospitals and clinics aiming to improve patient records, follow-up, and performance metrics across screening programs.

Therocoagulation add-on Promote ThermoGlide thermocoagulation as an immediate, point-of-care treatment option that complements screening programs, enabling end-to-end care in a single visit and increasing program value for health systems with limited resources.

Public funding signals Leverage recent awards, SBIR funding, and government collaborations to approach funders and government health ministries as potential co-funders or accelerators for national screening and breast cancer initiatives, enhancing credibility and speed to procurement.